News | ECG | February 11, 2022

Philips Introduces First At-Home, 12-Lead ECG Integrated Solution for Decentralized Clinical Trials

Philips expands remote cardiac monitoring portfolio with patch-based, clinical-grade ECG designed to improve patient recruitment, compliance and retention by reducing need for site visits during clinical trials.

Philips, a global leader in health technology, announced the introduction of the industry’s first full-service, at-home, 12-lead electrocardiogram (ECG) solution for use in decentralized clinical trials.

The solution’s innovative body-worn patch ensures compliant 12-lead ECG placement and near real-time, highly secure data transmission without the need for recurring site visits, onsite technician, or home nurses.


February 11, 2022 – Philips, a global leader in health technology, announced the introduction of the industry’s first full-service, at-home, 12-lead electrocardiogram (ECG) solution for use in decentralized clinical trials. The clinical-grade solution is the most advanced patient-centric ECG offering within the company’s cardiac monitoring portfolio, pairing data readings comparable to clinical, site-based ECGs with Philips leading cloud-based data collection and analysis services. This latest addition to Philips’ digitally enabled suite of monitoring solutions helps to drive innovation across the care continuum and support the decentralized clinical trial space.

Patient attrition is one of the biggest issues faced by clinical trial sponsors seeking regulatory approval for new therapies. Attrition over the course of a study can reduce the quality of its findings and can lead to longer, more expensive trials that require higher than optimal recruiting rates to compensate. Voluntary patient withdrawal is often tied to disease progression or the prolonged inconvenience of adhering to protocol regimens and repetitive site visits [1]. By offering the consistent and reliable standards of a 12-lead ECG in the comfort and convenience of a patient’s home, Philips at-home ECG solution aims to improve trial recruitment, compliance and patient retention by reducing the need for and burden of site visits.

“Our customers are seeking solutions that will help them to address key challenges that can stand in the way of extracting meaningful insights from their clinical trials,” said Andy Broadway, General Manager of Ambulatory Monitoring and Diagnostics at Philips. “Our growing portfolio of remote monitoring solutions help to curb patient attrition by reducing the amount of site visits required during the trial period, helping to improve both the quality of the outcome and the patient experience overall.”

Leveraging PCA 500 ECG patch data recording technology, the at-home solution allows clinical trial participants to record data with quality comparable to site-based ECGs at home. The solution’s innovative body-worn patch ensures compliant 12-lead ECG placement and near real-time, highly secure data transmission without the need for recurring site visits, onsite technician, or home nurses.

Philips offers a complete range of clinically validated ambulatory cardiac diagnostics and monitoring services and associated expertise to its cardiac care portfolio, including its BioTel Research capabilities that have already supported more than 2,000 clinical trials in 72 countries. These comprehensive offerings provide industry-leading technology and data management that streamlines the clinical trials process and ensures optimal performance. The at-home, 12-lead ECG solution is now available in select markets across North America, Europe and Asia.

[1] Hui D, Glitza I, Chisholm G, Yennu S, Bruera E. Attrition rates, reasons, and predictive factors in supportive care and palliative oncology clinical trials. Cancer. 2013;119(5):1098-1105. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3568443//PMC3568443/

For more information: https://www.usa.philips.com/healthcare


Related Content

News | ECG

August 17, 2022 — A new research paper was published in Aging (“Aging (Albany NY)” by Medline/PubMed, “Aging-US” by Web ...

Home August 17, 2022
Home
News | ECG

April 12, 2022 – Biotricity, a medical diagnostic and consumer healthcare technology company, will officially launch the ...

Home April 12, 2022
Home
News | ECG

April 4, 2022 – GE Healthcare and AliveCor have announced a partnership to deliver medical-grade six-lead ...

Home April 04, 2022
Home
News | ECG
February 14, 2022 – MediLynx Cardiac Monitoring, LLC (dba MediLynx Arrhythmia Diagnostics), a national remote monitoring ...
Home February 14, 2022
Home
News | ECG

September 1, 2021 — University of South Australia researchers have designed a computer vision system that can ...

Home September 01, 2021
Home
News | ECG

June 18, 2021 — You might be older ― or younger ― than you think. A new study found that differences between a person's ...

Home June 18, 2021
Home
News | ECG

February 16, 2021 — QT Medical recently announced the launch of Xpress ECG service, the world’s first 12-lead ECG home ...

Home February 16, 2021
Home
News | ECG

February 2, 2021 — Cardiac Insight, Inc. a healthcare company specializing in wearable cardiac sensors and automated ...

Home February 02, 2021
Home
Feature | ECG | By Dave Fornell, Editor

Here are a few trends to watch for in electrocardiogram (ECG, or if you prefer the original German EKG) systems. The ...

Home January 20, 2021
Home
Feature | ECG

Apple created a stir when it announced in 2018 that its Apple Watch Series 4 was the first consumer health and fitness ...

Home March 11, 2020
Home
Subscribe Now